At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Veriset™ Hemostatic Patchdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multi-Center, Single-Arm Study of the Veriset™ Hemostatic Patch in Controlling Bleeding in Soft Tissue
In Brief
A clinical study evaluating Veriset™ Hemostatic Patch for Non-emergent, Soft Tissue Procedures, Performed Via an Open Approach. Completed, enrolled 30 participants across 3 sites in 2 countries.
Detailed Summary
The objective of this study is to determine the safety of Veriset™ Hemostatic Patch when used during non-emergent, open, soft tissue surgery where a topical hemostatic agent would be used.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Germany
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2012
First PostedNov 2012
Primary CompletionMay 2013
Study CompletionJun 2013
TodayJul 2026
First PostedNov 1, 2012
Enrollment StartSep 1, 2012
Primary CompletionMay 1, 2013
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 13.7 years ago
Interventions
Veriset™ Hemostatic Patchdevice
Topical Hemostat